[et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.18.0″ _module_preset=”default” custom_margin_tablet=”-40px||||false|false” custom_margin_phone=”-40px||||false|false” custom_margin_last_edited=”on|tablet” custom_padding_tablet=”0px||||false|false” custom_padding_phone=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” header_font=”Playfair Display|700|||||||” header_text_color=”#000000″ header_font_size=”68px” header_4_font=”Roboto||on||||||” header_4_text_color=”#777777″ header_4_font_size=”24px” hover_enabled=”0″ header_font_size_tablet=”60px” header_font_size_phone=”46px” header_font_size_last_edited=”on|desktop” header_4_font_size_tablet=”22px” header_4_font_size_phone=”18px” header_4_font_size_last_edited=”on|phone” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” text_font=”Roboto|300|||||||” text_text_color=”#000000″ text_font_size=”16px” header_5_font=”Roboto||||||||” header_5_font_size=”20px” header_5_line_height=”1.3em” hover_enabled=”0″ header_5_font_size_tablet=”20px” header_5_font_size_phone=”18px” header_5_font_size_last_edited=”on|phone” global_colors_info=”{}” header_5_text_color=”#000000″ sticky_enabled=”0″]<\/p>\n
The current methods used to discover new drugs active on these proteins are based on cell models dissimilar to patient cells, drastically increasing the risk of failure in clinical trials.
Our patented ArcoFlow solution revolutionises drug discovery by directly testing the effect of a molecule on patient cells, thus enabling safer drugs to be brought to market quickly. ArcoFlow is the only automated, microfluidic test that identifies drugs active on this family of proteins directly on diseased patient cells.
ArcoScreen distributes its ArcoFlow technology as a service and as consumable kits for pharmaceutical companies.<\/p>\n